Digital Infuzion News

Digital Infuzion Proudly Supports Rare Disease Day 2020

Digital Infuzion is proud to participate in Rare Disease Day, a day where millions around the world paint their hands in solidarity and support of those living with rare diseases. Rare diseases affect just 3.5 to 5.9% of the global population, according to RareDiseaseDay.org, but that small percentage translates into 300 million men, women, and children around the world. This includes diseases such as Diffuse Intrinsic Pontine Glioma, or DIPG, a brainstem tumor that almost exclusively affects children.

Each year, Digital Infuzion’s charity initiative, RAD (Response@DIFZ), supports a cause and for 2020 it has identified DIPG as the focus of their efforts. Like any rare disease, DIPG tends to be overlooked and underfunded making the need for support and raising awareness all the more vital. With DIPG’s affected population being mostly children ages 4 to 11 years old, DIPG is a heartbreaking issue that Digital Infuzion hopes all will share in championing. On February 28, 2020, Digital Infuzion hosted a fundraiser to support DIPG, recognize Rare Disease Day, and raise donations for the Michael Mosier Defeat DIPG Foundation, a local charity started in honor of Michael Mosier, a 6-year-old who battled DIPG before passing away in 2015. This foundation has made remarkable strides in raising awareness and garnering the scientific and financial support needed to improve and save the lives of the children affected. We are proud to support this foundation in our 2020 charity initiative and look forward to the continued positive impact we can make together in the lives of those living with DIPG.
Author: Lyndi Scott
0 Comments

Categories: All Digital Infuzion News, Corporate News, FeaturedNumber of views: 793

Tags: